🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting products of unknown origin.

Several experts said the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.

Within minutes of entering one community, a vendor shared contact information, where most transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, posts display black plastic packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to potentially significant medical dangers”.